13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q3 2023 · Filed August 2, 2023 · Accession 0000904454-23-000459
Total Value
$322.1M
Positions
22
Other Managers
1
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $67.6M | 21.00% |
| 2 | Legend Biotech Corporation | LEGN | 814,586 | $56.2M | 17.46% |
| 3 | CVRx, Inc. | CVRX | 3,495,575 | $54.0M | 16.76% |
| 4 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $44.6M | 13.86% |
| 5 | Xencor, Inc. | XNCR | 748,062 | $18.7M | 5.80% |
| 6 | Fusion Pharmaceuticals Inc. | 36118A100 | 3,670,516 | $17.1M | 5.32% |
| 7 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $16.1M | 4.99% |
| 8 | Procept BioRobotics Corporation | PRCT | 357,939 | $12.7M | 3.93% |
| 9 | Point Biopharma Global Inc. | 730541109 | 1,000,000 | $9.1M | 2.81% |
| 10 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $8.8M | 2.74% |
| 11 | Nano-X Imaging Ltd. | NNOX | 317,704 | $4.9M | 1.53% |
| 12 | Vor Biopharma, Inc. | VOR | 1,074,658 | $3.3M | 1.03% |
| 13 | Aldeyra Therapeutics, Inc. | ALDX | 394,834 | $3.3M | 1.03% |
| 14 | Cue Health, Inc. | 229790100 | 5,548,864 | $2.0M | 0.64% |
| 15 | Adicet Bio, Inc. | ACET | 728,944 | $1.8M | 0.55% |
| 16 | BiomX Inc. | PHGE | 2,133,402 | $768,025 | 0.24% |
| 17 | SomaLogic, Inc. | 83444K105 | 281,052 | $649,230 | 0.20% |
| 18 | Clearside Biomedical, Inc. | CLSDQ | 169,629 | $189,984 | 0.06% |
| 19 | Apollomics, Inc. | APLMW | 13,252 | $75,934 | 0.02% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $41,681 | 0.01% |
| 21 | Tracon Pharmaceuticals, Inc. | 89237H209 | 84,003 | $24,445 | 0.01% |
| 22 | Catalyst Biosciences, Inc. | 14888D208 | 66,951 | $23,540 | 0.01% |